About this Journal Submit a Manuscript Table of Contents

Compliance with Prevention and Treatment for Hypertension and Related Cardiovascular Diseases

Call for Papers

Worldwide, one in three adults has raised blood pressure that leads to approximately half of all deaths from cardiovascular diseases. As a ubiquitous but preventable risk factor, high blood pressure contributes to coronary heart disease, stroke, heart failure, peripheral vascular disease, renal failure, and so on. The increasing risk of cardiovascular disease is associated with the increasing level of blood pressure. Hypertension is expected to increase by 60% by the year 2025, affecting 1.6 billion people.

In the last several decades, considerable progress has been made to identify a number of physiological and behavioural risk factors. The knowledge has been translated into international guidelines and reports on pharmacological treatments and lifestyle modification for disease prevention and management. However, the extent to which patient’s behaviour coincides with recommendations from healthcare providers remains a challenge facing the guidelines.

We invite researchers to contribute original research articles as well as review articles which would add to the evidence to explore different aspects related to the levels of patient’s compliance with prevention and treatment for hypertension and related cardiovascular diseases. Potential topics include, but are not limited to:

  • Development of instrument on compliance measurement
  • Compliance with antihypertensive and lipid-lowering agents
  • Adherence to medications of other related cardiovascular diseases
  • Factors associated with patient’s compliance with pharmacological and nonpharmacological regimen
  • Effectiveness of interventions to enhance the compliance with pharmacological and nonpharmacological therapy
  • Relationship between compliance with nonpharmacological recommendations (diet, weighing, exercise, and so on) and outcomes in patients with cardiovascular diseases
  • Patient’s quality of life related to the compliance with antihypertensive therapy

Before submission authors should carefully read over the journal’s Author Guidelines, which are located at http://www.hindawi.com/journals/ijht/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/ijht/hcd/ according to the following timetable:

Manuscript DueFriday, 2 August 2013
First Round of ReviewsFriday, 25 October 2013
Publication DateFriday, 20 December 2013

Lead Guest Editor

  • Martin C. S. Wong, School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong

Guest Editors

  • Bryan P. Yan, Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong
  • Clayton Dyck, Department of Family Medicine, University of Manitoba, Winnipeg, MB, Canada
  • Wei Yin Lim, Clinical Research Centre Perak, Hospital Raja Permaisuri Bainun, Ipoh, Malaysia
  • Harry H. X. Wang, School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong
  • Mandy Kwan, School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong